A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with...

por Malorni, Luca, Piazza, Silvano, Ciani, Yari, Guarducci, Cristina, Bonechi, Martina, Biagioni, Chiara, Hart, Christopher D., Verardo, Roberto, Leo, Angelo Di, Migliaccio, Ilenia
Publicado 2016

ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data

por Romagnoli, Dario, Boccalini, Giulia, Bonechi, Martina, Biagioni, Chiara, Fassan, Paola, Bertorelli, Roberto, Sanctis, Veronica De, Leo, Angelo Di, Migliaccio, Ilenia, Malorni, Luca, Benelli, Matteo
Publicado 2018

Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM Trial

por Leo, Angelo Di, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N., Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L., Smirnova, Iya, Lichinitser, Mikhail R., Pendergrass, Kelly, Malorni, Luca, Garnett, Sally, Rukazenkov, Yuri, Martin, Miguel
Publicado 2013

Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from t...

por Fernández-Cuesta, Lynnette, Oakman, Catherine, Falagan-Lotsch, Priscila, Smoth, Ke-seay, Quinaux, Emmanuel, Buyse, Marc, Dolci, M Stella, Azambuja, Evandro De, Hainaut, Pierre, Dell'Orto, Patrizia, Larsimont, Denis, Francis, Prudence A, Crown, John, Piccart-Gebhart, Martine, Viale, Giuseppe, Leo, Angelo Di, Olivier, Magali
Publicado 2012